• Return to Headlines

Staar Surgical: The Winning Streak Continues (STAA)

By Amy Schwartz

Staar Surgical (NASDAQ:STAA) traded at a new 52-week high today of $23.36. So far today approximately 108,000 shares have been exchanged, as compared to an average 30-day volume of 88,000 shares.

STAAR Surgical Company develops, manufactures, and markets high margin visual implants that improve a patient's quality of vision. The Company manufactures implantable contact lenses to treat refractive disorders such as myopia. STAAR also manufactures products for cataract surgery and glaucoma surgery.

In the past 52 weeks, Staar Surgical share prices have been bracketed by a low of $5.12 and a high of $23.36 and are now at $23.00, 349% above that low price. Over the past week, the 200-day moving average (MA) has gone down 0.5% while the 50-day MA has advanced 1.5%.

Based on a current price of $23.00, Staar Surgical is currently 18.5% above its average consensus analyst price target of $18.75. The stock should find initial support at its 200-day moving average (MA) of $7.60 and further support at its 50-day MA of $7.36.

SmarTrend recommended that subscribers consider buying shares of Staar Surgical on April 18th, 2018 as our proprietary SmarTrend analytics indicated a new Uptrend was in progress when shares hit $15.63. Since that recommendation, shares of Staar Surgical have risen 43.0%. We continue to monitor STAA for any potential shift so investors can protect gains and will alert SmarTrend subscribers immediately.

Keywords: 52 week high/lows staar surgical

Ticker(s): STAA